HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ivana Sestak Selected Research

Anastrozole (Arimidex)

1/2022Comparison of StemPrintER with Oncotype DX Recurrence Score for predicting risk of breast cancer distant recurrence after endocrine therapy.
7/2021The impact of body mass index on breast cancer incidence among women at increased risk: an observational study from the International Breast Intervention Studies.
2/2021Development and validation for research assessment of Oncotype DX® Breast Recurrence Score, EndoPredict® and Prosigna®.
1/2021Off-treatment bone mineral density changes in postmenopausal women receiving anastrozole for 5 years: 7-year results from the IBIS-II prevention trial.
11/2020Use of anastrozole for breast cancer prevention (IBIS-II): long-term results of a randomised controlled trial.
1/2019Comparison of risedronate versus placebo in preventing anastrozole-induced bone loss in women at high risk of developing breast cancer with osteopenia.
1/2018Relevance of Spatial Heterogeneity of Immune Infiltration for Predicting Risk of Recurrence After Endocrine Therapy of ER+ Breast Cancer.
2/2016Anastrozole versus tamoxifen for the prevention of locoregional and contralateral breast cancer in postmenopausal women with locally excised ductal carcinoma in situ (IBIS-II DCIS): a double-blind, randomised controlled trial.
1/2016Anastrozole-Induced Carpal Tunnel Syndrome: Results From the International Breast Cancer Intervention Study II Prevention Trial.
6/2015Estrogen Receptor Expression in 21-Gene Recurrence Score Predicts Increased Late Recurrence for Estrogen-Positive/HER2-Negative Breast Cancer.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ivana Sestak Research Topics

Disease

58Breast Neoplasms (Breast Cancer)
01/2022 - 08/2006
20Neoplasms (Cancer)
01/2022 - 02/2007
6Noninfiltrating Intraductal Carcinoma (DCIS)
11/2020 - 01/2011
4Endometrial Neoplasms (Endometrial Cancer)
11/2016 - 12/2010
3Venous Thrombosis (Deep-Vein Thrombosis)
02/2016 - 02/2007
2Melanoma (Melanoma, Malignant)
11/2020 - 12/2010
2Carpal Tunnel Syndrome
01/2016 - 10/2009
2Arthralgia (Joint Pain)
12/2014 - 09/2008
2Pulmonary Embolism
06/2012 - 02/2007
1Chronic Disease (Chronic Diseases)
06/2021
1Skin Neoplasms (Skin Cancer)
11/2020
1Metabolic Bone Diseases (Osteopenia)
01/2019
1Nausea
10/2017
1Headache (Headaches)
10/2017
1Vomiting
10/2017
1Genetic Risk Score
03/2017
1Spasm (Spasms)
02/2016
1Stroke (Strokes)
02/2016
1Hyperplasia
11/2015
1Breast Diseases (Breast Disease)
11/2015
1Cysts
11/2015
1Carcinogenesis
06/2015
1Colorectal Neoplasms (Colorectal Cancer)
03/2015
1Disease Progression
01/2014
1West Nile Fever
09/2013
1Weight Gain
07/2012
1Venous Thromboembolism
06/2012
1Thromboembolism
06/2012
1Lung Neoplasms (Lung Cancer)
12/2010
1Ovarian Neoplasms (Ovarian Cancer)
12/2010
1Overweight
07/2010
1Arthritis (Polyarthritis)
09/2008
1Obesity
09/2008

Drug/Important Bio-Agent (IBA)

34TamoxifenFDA LinkGeneric
01/2022 - 08/2006
25Anastrozole (Arimidex)FDA LinkGeneric
01/2022 - 09/2008
12Aromatase InhibitorsIBA
11/2020 - 09/2008
12Hormones (Hormone)IBA
01/2020 - 09/2008
11Estrogen ReceptorsIBA
01/2021 - 02/2007
5Biomarkers (Surrogate Marker)IBA
01/2022 - 10/2013
42- benzylidene- 3- (cyclohexylamino)- 2,3- dihydro- 1H- inden- 1- oneIBA
10/2021 - 10/2013
4Selective Estrogen Receptor Modulators (SERM)IBA
01/2016 - 12/2012
4Raloxifene Hydrochloride (Evista)FDA Link
01/2016 - 12/2012
4Estrogens (Estrogen)FDA Link
06/2015 - 10/2009
2RNA (Ribonucleic Acid)IBA
02/2021 - 03/2012
2Risedronic Acid (Actonel)FDA LinkGeneric
01/2019 - 12/2014
2Formaldehyde (Formol)FDA Link
08/2015 - 03/2012
2Progesterone Receptors (Progesterone Receptor)IBA
06/2015 - 03/2012
2Proteins (Proteins, Gene)FDA Link
06/2015 - 03/2012
1ErbB Receptors (EGF Receptor)IBA
01/2022
1Biological ProductsIBA
01/2022
1sperm releasing substanceIBA
01/2022
1AdipokinesIBA
06/2021
1ImmunosorbentsIBA
06/2021
1EnzymesIBA
06/2021
1AdiponectinIBA
06/2021
1LeptinIBA
06/2021
1Hematoxylin (Haematoxylon)IBA
01/2018
1Eosine Yellowish-(YS) (Eosin)IBA
01/2018
1human ERBB2 proteinIBA
11/2016
1ParaffinIBA
08/2015
1Phenobarbital (Luminal)FDA Link
08/2015
1mahuang-tangIBA
06/2015
1Protein Isoforms (Isoforms)IBA
06/2015
1Pharmaceutical PreparationsIBA
01/2015
1CarcinogensIBA
01/2014
1IntegrinsIBA
01/2014
1LasofoxifeneIBA
01/2014
1exemestane (Aromasin)FDA Link
01/2014
1LY 353381 (LY353381)IBA
01/2014
1Indicators and Reagents (Reagents)IBA
09/2013
1Messenger RNA (mRNA)IBA
08/2013
1antineoplaston A10 (A 10)IBA
05/2013
1Cytochrome P-450 CYP2D6 (CYP2D6)IBA
03/2012
14-hydroxy-N-desmethyltamoxifenIBA
03/2012
1ProgesteroneFDA LinkGeneric
07/2010

Therapy/Procedure

29Therapeutics
01/2022 - 10/2009
4Drug Therapy (Chemotherapy)
07/2019 - 09/2008
4Adjuvant Chemotherapy
07/2019 - 10/2016
2Aftercare (After-Treatment)
11/2020 - 01/2015
2Radiotherapy
11/2016 - 01/2011
1Contraindications
02/2016
1Chemoprevention
06/2012